{
    "xml": "<topic id=\"PHP4491\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/medroxyprogesterone-acetate\" basename=\"medroxyprogesterone-acetate\" title=\"MEDROXYPROGESTERONE ACETATE\">\n<title>MEDROXYPROGESTERONE ACETATE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_672\" namespace=\"/interactions/list-of-drug-interactions/progestogens/medroxyprogesterone\">Medroxyprogesterone</xref>\n</p>\n<data name=\"vtmid\">36621009</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_203813864\" title=\"Progestogens\">Progestogens</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\r\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP49973\" outputclass=\"indicationsAndDose\" rev=\"1.49\" parent=\"/drugs/medroxyprogesterone-acetate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Dysfunctional uterine bleeding</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2.5&#8211;10&#8239;mg daily for 5&#8211;10 days, repeated for 2 cycles, begin treatment on day 16&#8211;21 of cycle.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Secondary amenorrhoea</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2.5&#8211;10&#8239;mg daily for 5&#8211;10 days, repeated for 3 cycles, begin treatment on day 16&#8211;21 of cycle.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Mild to moderate endometriosis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8239;mg 3 times a day for 90 consecutive days, begin treatment on day 1 of cycle.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Progestogenic opposition of oestrogen HRT</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8239;mg daily for the last 14 days of each 28-day oestrogen HRT cycle.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Endometrial cancer</p>\n<p outputclass=\"therapeuticIndication\">Renal cell cancer</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8211;600&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Breast cancer</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.4&#8211;1.5&#8239;g daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Contraception</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By deep intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Females of childbearing potential</p>\n<p>150&#8239;mg, to be administered within the first 5 days of cycle or within first 5 days after parturition (delay until 6 weeks after parturition if breast-feeding).</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Females of childbearing potential</p>\n<p>104&#8239;mg, to be administered within first 5 days of cycle or within 5 days postpartum (delay until 6 weeks postpartum if breast-feeding), injected into anterior thigh or abdomen, dose only suitable if no hormonal contraceptive use in previous month.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Long-term contraception</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By deep intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Females of childbearing potential</p>\n<p>150&#8239;mg every 12&#8239;weeks, to be administered within the first 5 days of cycle or within first 5 days after parturition (delay until 6 weeks after parturition if breast-feeding).</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Females of childbearing potential</p>\n<p>104&#8239;mg every 13&#8239;weeks, to be administered within first 5 days of cycle or within 5 days postpartum (delay until 6 weeks postpartum if breast-feeding), injected into anterior thigh or abdomen, dose only suitable if no hormonal contraceptive use in previous month.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Contraception (when patient changing from other hormonal contraception)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Females of childbearing potential</p>\n<p>(consult product literature).</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64312\" outputclass=\"contraindications\" rev=\"1.33\" parent=\"/drugs/medroxyprogesterone-acetate\">\n<title>Contra-indications</title>\n<body>\r\n<section outputclass=\"contraindications\">\r\n<title>General contraindications:</title>\r\n<p>\r\n<ph outputclass=\"contraindication\">\r\n<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"contraindication\">severe arterial disease</ph>; <ph outputclass=\"contraindication\">undiagnosed vaginal bleeding</ph>\r\n</p>\r\n<sectiondiv outputclass=\"additionalContraindications\">\r\n<p outputclass=\"title\">Specific contraindications:</p>\r\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\r\n<p outputclass=\"title\">With intramuscular use</p>\r\n<p>\r\n<ph outputclass=\"contraindication\">history of breast cancer but can be used after 5 years if no evidence of disease and non-hormonal contraceptive methods unacceptable</ph>\r\n</p>\n</sectiondiv>\r\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\r\n<p outputclass=\"title\">With oral use</p>\r\n<p>\r\n<ph outputclass=\"contraindication\">breast cancer (unless progestogens are being used in the management of this condition)</ph>; <ph outputclass=\"contraindication\">genital cancer (unless progestogens are being used in the management of this condition)</ph>; <ph outputclass=\"contraindication\">history of liver tumours</ph>\r\n</p>\n</sectiondiv>\r\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\r\n<p outputclass=\"title\">With subcutaneous use</p>\r\n<p>\r\n<ph outputclass=\"contraindication\">history of breast cancer but can be used after 5 years if no evidence of disease and non-hormonal contraceptive methods unacceptable</ph>\r\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP64665\" outputclass=\"cautions\" rev=\"1.22\" parent=\"/drugs/medroxyprogesterone-acetate\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<title>General cautions:</title>\n<p>\n<ph outputclass=\"caution\">Possible risk of breast cancer</ph>\n</p>\n<sectiondiv outputclass=\"additionalCautions\">\n<p outputclass=\"title\">Specific cautions:</p>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With intramuscular use</p>\n<p>\n<ph outputclass=\"caution\">history during pregnancy in disturbances of lipid metabolism</ph>; <ph outputclass=\"caution\">history during pregnancy of deterioration of otosclerosis</ph>; <ph outputclass=\"caution\">history during pregnancy of pruritus</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With oral use</p>\n<p>\n<ph outputclass=\"caution\">asthma</ph>; <ph outputclass=\"caution\">cardiac dysfunction</ph>; <ph outputclass=\"caution\">conditions that may worsen with fluid retention</ph>; <ph outputclass=\"caution\">diabetes (progestogens can decrease glucose tolerance&#8212;monitor patient closely)</ph>; <ph outputclass=\"caution\">epilepsy</ph>; <ph outputclass=\"caution\">history of depression</ph>; <ph outputclass=\"caution\">hypertension</ph>; <ph outputclass=\"caution\">migraine</ph>; <ph outputclass=\"caution\">susceptibility to thromboembolism (particular caution with high dose)</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With subcutaneous use</p>\n<p>\n<ph outputclass=\"caution\">history during pregnancy in disturbances of lipid metabolism</ph>; <ph outputclass=\"caution\">history during pregnancy of deterioration of otosclerosis</ph>; <ph outputclass=\"caution\">history during pregnancy of pruritus</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49878\" outputclass=\"interactions\" rev=\"1.14\" parent=\"/drugs/medroxyprogesterone-acetate\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (progestogens).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use</p>\n<p>Effectiveness of parenteral progestogen-only contraceptives is not affected by antibacterials that do not induce liver enzymes. The effectiveness of medroxyprogesterone acetate intramuscular and subcutaneous injections is not affected by enzyme-inducing drugs and they may be continued as normal during courses of these drugs.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49410\" outputclass=\"sideEffects\" rev=\"1.68\" parent=\"/drugs/medroxyprogesterone-acetate\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Breast discomfort</ph>; <ph outputclass=\"sideEffect\">changes in libido</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">indigestion</ph>; <ph outputclass=\"sideEffect\">loss of vision during treatment (discontinue treatment if papilloedema or retinal vascular lesions)</ph>; <ph outputclass=\"sideEffect\">menstrual irregularities</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>; <ph outputclass=\"sideEffect\">weight gain</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intramuscular use</p>\n<p>\n<ph outputclass=\"sideEffect\">osteoporosis</ph>; <ph outputclass=\"sideEffect\">osteoporotic fractures</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With subcutaneous use</p>\n<p>\n<ph outputclass=\"sideEffect\">osteoporosis</ph>; <ph outputclass=\"sideEffect\">osteoporotic fractures</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intramuscular use</p>\n<p>\n<ph outputclass=\"sideEffect\">disturbance of appetite</ph>; <ph outputclass=\"sideEffect\">injection site-reactions</ph>; <ph outputclass=\"sideEffect\">reduced bone mineral density</ph>; <ph outputclass=\"sideEffect\">skin disorders</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With oral use</p>\n<p>\n<ph outputclass=\"sideEffect\">acne</ph>; <ph outputclass=\"sideEffect\">adrenergic-like effects (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">alopecia</ph>; <ph outputclass=\"sideEffect\">anaphylactoid reactions</ph>; <ph outputclass=\"sideEffect\">bloating</ph>; <ph outputclass=\"sideEffect\">breast tenderness</ph>; <ph outputclass=\"sideEffect\">cervical erosions (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">confusion (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">congestive heart failure (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">constipation (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">diarrhoea (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">dry mouth (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">euphoria (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">fluid retention</ph>; <ph outputclass=\"sideEffect\">galactorrhoea (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">glucocorticoid effects may lead to a cushingoid syndrome (with high doses for malignant disease)</ph>; <ph outputclass=\"sideEffect\">hirsutism</ph>; <ph outputclass=\"sideEffect\">hypercalcaemia (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">hyperpyrexia (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">hypertension (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">insomnia</ph>; <ph outputclass=\"sideEffect\">jaundice</ph>; <ph outputclass=\"sideEffect\">loss of concentration (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">nervousness (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">palpitation (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">premenstrual-like syndrome</ph>; <ph outputclass=\"sideEffect\">raised platelet count (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">raised white blood cell count (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">retinal thrombosis (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">skin reactions</ph>; <ph outputclass=\"sideEffect\">tachycardia (when used for malignant disease)</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>; <ph outputclass=\"sideEffect\">vision disorders (when used for malignant disease)</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With subcutaneous use</p>\n<p>\n<ph outputclass=\"sideEffect\">disturbance of appetite</ph>; <ph outputclass=\"sideEffect\">injection site-reactions</ph>; <ph outputclass=\"sideEffect\">reduced bone mineral density</ph>; <ph outputclass=\"sideEffect\">skin disorders</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use</p>\n<p outputclass=\"title\">Cervical cancer</p>\n<p>Use of injectable progestogen-only contraceptives may be associated with a small increased risk of cervical cancer, similar to that seen with combined oral contraceptives. The risk of cervical cancer with other progestogen-only contraceptives is not yet known.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use</p>\n<p>Reduction in bone mineral density occurs in the first 2&#8211;3 years of use then stabilises.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64529\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/medroxyprogesterone-acetate\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use</p>\n<p>If interval between dose is greater than 12 weeks and 5 days (in long-term contraception), rule out pregnancy before next injection and advise patient to use additional contraceptive measures (e.g. barrier) for 14 days after the injection.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">subcutaneous</ph> use</p>\n<p>If interval between dose is greater than 13 weeks and 7 days (in long-term contraception), rule out pregnancy before next injection.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49785\" outputclass=\"pregnancy\" parent=\"/drugs/medroxyprogesterone-acetate\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\n<p>Avoid&#8212;genital malformations and cardiac defects reported.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use</p>\n<p>Not known to be harmful.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64795\" outputclass=\"breastFeeding\" parent=\"/drugs/medroxyprogesterone-acetate\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Present in milk&#8212;no adverse effects reported. Progesterone-only contraceptives do not affect lactation.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use</p>\n<p>The manufacturers advise that in women who are breast-feeding, the first dose should be delayed until 6 weeks after birth; however, evidence suggests no harmful effect to infant if given earlier. The benefits of using medroxyprogesterone acetate in breast-feeding women outweigh any risks.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP50245\" outputclass=\"hepaticImpairment\" parent=\"/drugs/medroxyprogesterone-acetate\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\n<p>Avoid in hepatic impairment.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use</p>\n<p>Caution in severe liver disease and recurrent cholestatic jaundice.</p>\n<p>Avoid in liver tumour.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49604\" outputclass=\"renalImpairment\" parent=\"/drugs/medroxyprogesterone-acetate\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">When used for <ph outputclass=\"indication\">Mild to moderate endometriosis</ph> or <ph outputclass=\"indication\">Progestogenic opposition of oestrogen HRT</ph> or <ph outputclass=\"indication\">Dysfunctional uterine bleeding</ph> or <ph outputclass=\"indication\">Secondary amenorrhoea</ph>\n</p>\n<p>Use with caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49697\" outputclass=\"patientAndCarerAdvice\" rev=\"1.14\" parent=\"/drugs/medroxyprogesterone-acetate\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use</p>\n<p>Full counselling backed by <i>patient information leaflet</i> required before administration&#8212;likelihood of menstrual disturbance and the potential for a delay in return to full fertility. Delayed return of fertility and irregular cycles may occur after discontinuation of treatment but there is no evidence of permanent infertility.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP4491-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/medroxyprogesterone-acetate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension, oral solution</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75466\" title=\"Tablet\" namespace=\"/drugs/medroxyprogesterone-acetate/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75484\" title=\"Suspension for injection\" namespace=\"/drugs/medroxyprogesterone-acetate/suspension-for-injection\">Suspension for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85587\" namespace=\"/drugs/conjugated-oestrogens-with-medroxyprogesterone\" title=\"CONJUGATED OESTROGENS WITH MEDROXYPROGESTERONE\" count=\"1\" rel=\"backlink\">CONJUGATED OESTROGENS WITH MEDROXYPROGESTERONE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85597\" namespace=\"/drugs/estradiol-with-medroxyprogesterone\" title=\"ESTRADIOL WITH MEDROXYPROGESTERONE\" count=\"1\" rel=\"backlink\">ESTRADIOL WITH MEDROXYPROGESTERONE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78143\" namespace=\"/treatment-summaries/contraceptives-interactions\" title=\"Contraceptives, interactions\" count=\"1\" rel=\"backlink\">Contraceptives, interactions</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78400\" namespace=\"/treatment-summaries/sex-hormones\" title=\"Sex hormones\" count=\"1\" rel=\"backlink\">Sex hormones</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78485\" namespace=\"/treatment-summaries/contraceptives-hormonal\" title=\"Contraceptives, hormonal\" count=\"2\" rel=\"backlink\">Contraceptives, hormonal</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78591\" namespace=\"/treatment-summaries/hormones-malignant-disease\" title=\"Hormones, malignant disease\" count=\"2\" rel=\"backlink\">Hormones, malignant disease</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_672\" namespace=\"/interactions/list-of-drug-interactions/progestogens/medroxyprogesterone\" title=\"Medroxyprogesterone\" count=\"1\" rel=\"link\">Medroxyprogesterone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75466\" namespace=\"/drugs/medroxyprogesterone-acetate/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75484\" namespace=\"/drugs/medroxyprogesterone-acetate/suspension-for-injection\" title=\"Suspension for injection\" count=\"1\" rel=\"link\">Suspension for injection</xref>\n</links>\n</topic>",
    "id": "PHP4491",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/medroxyprogesterone-acetate",
    "basename": "medroxyprogesterone-acetate",
    "title": "MEDROXYPROGESTERONE ACETATE",
    "interactants": [
        {
            "id": "bnf_int_672",
            "label": "Medroxyprogesterone"
        }
    ],
    "vtmid": "36621009",
    "drugClassification": [
        "Progestogens"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Dysfunctional uterine bleeding",
                        "html": "Dysfunctional uterine bleeding"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "2.5&#8211;10 mg daily for 5&#8211;10 days, repeated for 2 cycles, begin treatment on day 16&#8211;21 of cycle.",
                        "html": "<p>2.5&#8211;10&#8239;mg daily for 5&#8211;10 days, repeated for 2 cycles, begin treatment on day 16&#8211;21 of cycle.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Secondary amenorrhoea",
                        "html": "Secondary amenorrhoea"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "2.5&#8211;10 mg daily for 5&#8211;10 days, repeated for 3 cycles, begin treatment on day 16&#8211;21 of cycle.",
                        "html": "<p>2.5&#8211;10&#8239;mg daily for 5&#8211;10 days, repeated for 3 cycles, begin treatment on day 16&#8211;21 of cycle.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Mild to moderate endometriosis",
                        "html": "Mild to moderate endometriosis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "10 mg 3 times a day for 90 consecutive days, begin treatment on day 1 of cycle.",
                        "html": "<p>10&#8239;mg 3 times a day for 90 consecutive days, begin treatment on day 1 of cycle.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Progestogenic opposition of oestrogen HRT",
                        "html": "Progestogenic opposition of oestrogen HRT"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "10 mg daily for the last 14 days of each 28-day oestrogen HRT cycle.",
                        "html": "<p>10&#8239;mg daily for the last 14 days of each 28-day oestrogen HRT cycle.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Endometrial cancer",
                        "html": "Endometrial cancer"
                    },
                    {
                        "textContent": "Renal cell cancer",
                        "html": "Renal cell cancer"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "200&#8211;600 mg daily.",
                        "html": "<p>200&#8211;600&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Breast cancer",
                        "html": "Breast cancer"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "0.4&#8211;1.5 g daily.",
                        "html": "<p>0.4&#8211;1.5&#8239;g daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Contraception",
                        "html": "Contraception"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "150 mg, to be administered within the first 5 days of cycle or within first 5 days after parturition (delay until 6 weeks after parturition if breast-feeding).",
                        "html": "<p>150&#8239;mg, to be administered within the first 5 days of cycle or within first 5 days after parturition (delay until 6 weeks after parturition if breast-feeding).</p>",
                        "ageGroup": "females of childbearing potential"
                    },
                    {
                        "textContent": "104 mg, to be administered within first 5 days of cycle or within 5 days postpartum (delay until 6 weeks postpartum if breast-feeding), injected into anterior thigh or abdomen, dose only suitable if no hormonal contraceptive use in previous month.",
                        "html": "<p>104&#8239;mg, to be administered within first 5 days of cycle or within 5 days postpartum (delay until 6 weeks postpartum if breast-feeding), injected into anterior thigh or abdomen, dose only suitable if no hormonal contraceptive use in previous month.</p>",
                        "ageGroup": "females of childbearing potential"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Long-term contraception",
                        "html": "Long-term contraception"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "150 mg every 12 weeks, to be administered within the first 5 days of cycle or within first 5 days after parturition (delay until 6 weeks after parturition if breast-feeding).",
                        "html": "<p>150&#8239;mg every 12&#8239;weeks, to be administered within the first 5 days of cycle or within first 5 days after parturition (delay until 6 weeks after parturition if breast-feeding).</p>",
                        "ageGroup": "females of childbearing potential"
                    },
                    {
                        "textContent": "104 mg every 13 weeks, to be administered within first 5 days of cycle or within 5 days postpartum (delay until 6 weeks postpartum if breast-feeding), injected into anterior thigh or abdomen, dose only suitable if no hormonal contraceptive use in previous month.",
                        "html": "<p>104&#8239;mg every 13&#8239;weeks, to be administered within first 5 days of cycle or within 5 days postpartum (delay until 6 weeks postpartum if breast-feeding), injected into anterior thigh or abdomen, dose only suitable if no hormonal contraceptive use in previous month.</p>",
                        "ageGroup": "females of childbearing potential"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Contraception (when patient changing from other hormonal contraception)",
                        "html": "Contraception (when patient changing from other hormonal contraception)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "(consult product literature).",
                        "html": "<p>(consult product literature).</p>",
                        "ageGroup": "females of childbearing potential"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Acute porphyrias",
                "html": "<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "contraindications",
                "textContent": "severe arterial disease",
                "html": "severe arterial disease"
            },
            {
                "type": "contraindications",
                "textContent": "undiagnosed vaginal bleeding",
                "html": "undiagnosed vaginal bleeding"
            }
        ],
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "history of breast cancer but can be used after 5 years if no evidence of disease and non-hormonal contraceptive methods unacceptable",
                "html": "history of breast cancer but can be used after 5 years if no evidence of disease and non-hormonal contraceptive methods unacceptable",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With intramuscular use",
                    "routes": [
                        "intramuscular"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "breast cancer (unless progestogens are being used in the management of this condition)",
                "html": "breast cancer (unless progestogens are being used in the management of this condition)",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "genital cancer (unless progestogens are being used in the management of this condition)",
                "html": "genital cancer (unless progestogens are being used in the management of this condition)",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "history of liver tumours",
                "html": "history of liver tumours",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "history of breast cancer but can be used after 5 years if no evidence of disease and non-hormonal contraceptive methods unacceptable",
                "html": "history of breast cancer but can be used after 5 years if no evidence of disease and non-hormonal contraceptive methods unacceptable",
                "specificity": {
                    "textContent": "With subcutaneous use",
                    "html": "With subcutaneous use",
                    "routes": [
                        "subcutaneous"
                    ]
                }
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Possible risk of breast cancer",
                "html": "Possible risk of breast cancer"
            }
        ],
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "history during pregnancy in disturbances of lipid metabolism",
                "html": "history during pregnancy in disturbances of lipid metabolism",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With intramuscular use",
                    "routes": [
                        "intramuscular"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "history during pregnancy of deterioration of otosclerosis",
                "html": "history during pregnancy of deterioration of otosclerosis",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With intramuscular use",
                    "routes": [
                        "intramuscular"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "history during pregnancy of pruritus",
                "html": "history during pregnancy of pruritus",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With intramuscular use",
                    "routes": [
                        "intramuscular"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "asthma",
                "html": "asthma",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "cardiac dysfunction",
                "html": "cardiac dysfunction",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "conditions that may worsen with fluid retention",
                "html": "conditions that may worsen with fluid retention",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "diabetes (progestogens can decrease glucose tolerance&#8212;monitor patient closely)",
                "html": "diabetes (progestogens can decrease glucose tolerance&#8212;monitor patient closely)",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "epilepsy",
                "html": "epilepsy",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "history of depression",
                "html": "history of depression",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "hypertension",
                "html": "hypertension",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "migraine",
                "html": "migraine",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "susceptibility to thromboembolism (particular caution with high dose)",
                "html": "susceptibility to thromboembolism (particular caution with high dose)",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "history during pregnancy in disturbances of lipid metabolism",
                "html": "history during pregnancy in disturbances of lipid metabolism",
                "specificity": {
                    "textContent": "With subcutaneous use",
                    "html": "With subcutaneous use",
                    "routes": [
                        "subcutaneous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "history during pregnancy of deterioration of otosclerosis",
                "html": "history during pregnancy of deterioration of otosclerosis",
                "specificity": {
                    "textContent": "With subcutaneous use",
                    "html": "With subcutaneous use",
                    "routes": [
                        "subcutaneous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "history during pregnancy of pruritus",
                "html": "history during pregnancy of pruritus",
                "specificity": {
                    "textContent": "With subcutaneous use",
                    "html": "With subcutaneous use",
                    "routes": [
                        "subcutaneous"
                    ]
                }
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (progestogens).",
                "html": "<p>Appendix 1 (progestogens).</p>"
            },
            {
                "type": "general",
                "specificity": {
                    "textContent": "With intramuscular use or subcutaneous use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use",
                    "routes": [
                        "intramuscular",
                        "subcutaneous"
                    ]
                },
                "textContent": "Effectiveness of parenteral progestogen-only contraceptives is not affected by antibacterials that do not induce liver enzymes. The effectiveness of medroxyprogesterone acetate intramuscular and subcutaneous injections is not affected by enzyme-inducing drugs and they may be continued as normal during courses of these drugs.",
                "html": "<p>Effectiveness of parenteral progestogen-only contraceptives is not affected by antibacterials that do not induce liver enzymes. The effectiveness of medroxyprogesterone acetate intramuscular and subcutaneous injections is not affected by enzyme-inducing drugs and they may be continued as normal during courses of these drugs.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Breast discomfort",
                        "html": "Breast discomfort",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "changes in libido",
                        "html": "changes in libido",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "indigestion",
                        "html": "indigestion",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "loss of vision during treatment (discontinue treatment if papilloedema or retinal vascular lesions)",
                        "html": "loss of vision during treatment (discontinue treatment if papilloedema or retinal vascular lesions)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "menstrual irregularities",
                        "html": "menstrual irregularities",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "weight gain",
                        "html": "weight gain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "rare": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "osteoporosis",
                        "html": "osteoporosis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "With intramuscular use",
                            "html": "With intramuscular use",
                            "routes": [
                                "intramuscular"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "osteoporotic fractures",
                        "html": "osteoporotic fractures",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "With intramuscular use",
                            "html": "With intramuscular use",
                            "routes": [
                                "intramuscular"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "osteoporosis",
                        "html": "osteoporosis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "With subcutaneous use",
                            "html": "With subcutaneous use",
                            "routes": [
                                "subcutaneous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "osteoporotic fractures",
                        "html": "osteoporotic fractures",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "With subcutaneous use",
                            "html": "With subcutaneous use",
                            "routes": [
                                "subcutaneous"
                            ]
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "disturbance of appetite",
                        "html": "disturbance of appetite",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intramuscular use",
                            "html": "With intramuscular use",
                            "routes": [
                                "intramuscular"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "injection site-reactions",
                        "html": "injection site-reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intramuscular use",
                            "html": "With intramuscular use",
                            "routes": [
                                "intramuscular"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "reduced bone mineral density",
                        "html": "reduced bone mineral density",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intramuscular use",
                            "html": "With intramuscular use",
                            "routes": [
                                "intramuscular"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "skin disorders",
                        "html": "skin disorders",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intramuscular use",
                            "html": "With intramuscular use",
                            "routes": [
                                "intramuscular"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "acne",
                        "html": "acne",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "adrenergic-like effects (when used for malignant disease)",
                        "html": "adrenergic-like effects (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "alopecia",
                        "html": "alopecia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "anaphylactoid reactions",
                        "html": "anaphylactoid reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "bloating",
                        "html": "bloating",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "breast tenderness",
                        "html": "breast tenderness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "cervical erosions (when used for malignant disease)",
                        "html": "cervical erosions (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "confusion (when used for malignant disease)",
                        "html": "confusion (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "congestive heart failure (when used for malignant disease)",
                        "html": "congestive heart failure (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "constipation (when used for malignant disease)",
                        "html": "constipation (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "diarrhoea (when used for malignant disease)",
                        "html": "diarrhoea (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "dry mouth (when used for malignant disease)",
                        "html": "dry mouth (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "euphoria (when used for malignant disease)",
                        "html": "euphoria (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "fluid retention",
                        "html": "fluid retention",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "galactorrhoea (when used for malignant disease)",
                        "html": "galactorrhoea (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "glucocorticoid effects may lead to a cushingoid syndrome (with high doses for malignant disease)",
                        "html": "glucocorticoid effects may lead to a cushingoid syndrome (with high doses for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "hirsutism",
                        "html": "hirsutism",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "hypercalcaemia (when used for malignant disease)",
                        "html": "hypercalcaemia (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "hyperpyrexia (when used for malignant disease)",
                        "html": "hyperpyrexia (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "hypertension (when used for malignant disease)",
                        "html": "hypertension (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "insomnia",
                        "html": "insomnia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "jaundice",
                        "html": "jaundice",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "loss of concentration (when used for malignant disease)",
                        "html": "loss of concentration (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "nervousness (when used for malignant disease)",
                        "html": "nervousness (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "palpitation (when used for malignant disease)",
                        "html": "palpitation (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "premenstrual-like syndrome",
                        "html": "premenstrual-like syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "raised platelet count (when used for malignant disease)",
                        "html": "raised platelet count (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "raised white blood cell count (when used for malignant disease)",
                        "html": "raised white blood cell count (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "retinal thrombosis (when used for malignant disease)",
                        "html": "retinal thrombosis (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "skin reactions",
                        "html": "skin reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "tachycardia (when used for malignant disease)",
                        "html": "tachycardia (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "vision disorders (when used for malignant disease)",
                        "html": "vision disorders (when used for malignant disease)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "disturbance of appetite",
                        "html": "disturbance of appetite",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With subcutaneous use",
                            "html": "With subcutaneous use",
                            "routes": [
                                "subcutaneous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "injection site-reactions",
                        "html": "injection site-reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With subcutaneous use",
                            "html": "With subcutaneous use",
                            "routes": [
                                "subcutaneous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "reduced bone mineral density",
                        "html": "reduced bone mineral density",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With subcutaneous use",
                            "html": "With subcutaneous use",
                            "routes": [
                                "subcutaneous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "skin disorders",
                        "html": "skin disorders",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With subcutaneous use",
                            "html": "With subcutaneous use",
                            "routes": [
                                "subcutaneous"
                            ]
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "specificity": {
                    "textContent": "With intramuscular use or subcutaneous use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use",
                    "routes": [
                        "intramuscular",
                        "subcutaneous"
                    ]
                },
                "title": "Cervical cancer",
                "textContent": "Use of injectable progestogen-only contraceptives may be associated with a small increased risk of cervical cancer, similar to that seen with combined oral contraceptives. The risk of cervical cancer with other progestogen-only contraceptives is not yet known.",
                "html": "<p>Use of injectable progestogen-only contraceptives may be associated with a small increased risk of cervical cancer, similar to that seen with combined oral contraceptives. The risk of cervical cancer with other progestogen-only contraceptives is not yet known.</p>"
            },
            {
                "type": "advice",
                "specificity": {
                    "textContent": "With intramuscular use or subcutaneous use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use",
                    "routes": [
                        "intramuscular",
                        "subcutaneous"
                    ]
                },
                "textContent": "Reduction in bone mineral density occurs in the first 2&#8211;3 years of use then stabilises.",
                "html": "<p>Reduction in bone mineral density occurs in the first 2&#8211;3 years of use then stabilises.</p>"
            }
        ]
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use",
                    "routes": [
                        "intramuscular"
                    ]
                },
                "textContent": "If interval between dose is greater than 12 weeks and 5 days (in long-term contraception), rule out pregnancy before next injection and advise patient to use additional contraceptive measures (e.g. barrier) for 14 days after the injection.",
                "html": "<p>If interval between dose is greater than 12 weeks and 5 days (in long-term contraception), rule out pregnancy before next injection and advise patient to use additional contraceptive measures (e.g. barrier) for 14 days after the injection.</p>"
            },
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With subcutaneous use",
                    "html": "With <ph outputclass=\"route\">subcutaneous</ph> use",
                    "routes": [
                        "subcutaneous"
                    ]
                },
                "textContent": "If interval between dose is greater than 13 weeks and 7 days (in long-term contraception), rule out pregnancy before next injection.",
                "html": "<p>If interval between dose is greater than 13 weeks and 7 days (in long-term contraception), rule out pregnancy before next injection.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With <ph outputclass=\"route\">oral</ph> use",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Avoid&#8212;genital malformations and cardiac defects reported.",
                "html": "<p>Avoid&#8212;genital malformations and cardiac defects reported.</p>"
            },
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With intramuscular use or subcutaneous use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use",
                    "routes": [
                        "intramuscular",
                        "subcutaneous"
                    ]
                },
                "textContent": "Not known to be harmful.",
                "html": "<p>Not known to be harmful.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Present in milk&#8212;no adverse effects reported. Progesterone-only contraceptives do not affect lactation.",
                "html": "<p>Present in milk&#8212;no adverse effects reported. Progesterone-only contraceptives do not affect lactation.</p>"
            },
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With intramuscular use or subcutaneous use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use",
                    "routes": [
                        "intramuscular",
                        "subcutaneous"
                    ]
                },
                "textContent": "The manufacturers advise that in women who are breast-feeding, the first dose should be delayed until 6 weeks after birth; however, evidence suggests no harmful effect to infant if given earlier. The benefits of using medroxyprogesterone acetate in breast-feeding women outweigh any risks.",
                "html": "<p>The manufacturers advise that in women who are breast-feeding, the first dose should be delayed until 6 weeks after birth; however, evidence suggests no harmful effect to infant if given earlier. The benefits of using medroxyprogesterone acetate in breast-feeding women outweigh any risks.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With <ph outputclass=\"route\">oral</ph> use",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Avoid in hepatic impairment.",
                "html": "<p>Avoid in hepatic impairment.</p>"
            },
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With intramuscular use or subcutaneous use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use",
                    "routes": [
                        "intramuscular",
                        "subcutaneous"
                    ]
                },
                "textContent": "Caution in severe liver disease and recurrent cholestatic jaundice.\n\nAvoid in liver tumour.",
                "html": "<p>Caution in severe liver disease and recurrent cholestatic jaundice.</p><p>Avoid in liver tumour.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "When used for Mild to moderate endometriosis or Progestogenic opposition of oestrogen HRT or Dysfunctional uterine bleeding or Secondary amenorrhoea",
                    "html": "When used for <ph outputclass=\"indication\">Mild to moderate endometriosis</ph> or <ph outputclass=\"indication\">Progestogenic opposition of oestrogen HRT</ph> or <ph outputclass=\"indication\">Dysfunctional uterine bleeding</ph> or <ph outputclass=\"indication\">Secondary amenorrhoea</ph>",
                    "indications": [
                        "Mild to moderate endometriosis",
                        "Progestogenic opposition of oestrogen HRT",
                        "Dysfunctional uterine bleeding",
                        "Secondary amenorrhoea"
                    ]
                },
                "textContent": "Use with caution.",
                "html": "<p>Use with caution.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "specificity": {
                    "textContent": "With intramuscular use or subcutaneous use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use",
                    "routes": [
                        "intramuscular",
                        "subcutaneous"
                    ]
                },
                "textContent": "Full counselling backed by patient information leaflet required before administration&#8212;likelihood of menstrual disturbance and the potential for a delay in return to full fertility. Delayed return of fertility and irregular cycles may occur after discontinuation of treatment but there is no evidence of permanent infertility.",
                "html": "<p>Full counselling backed by <i>patient information leaflet</i> required before administration&#8212;likelihood of menstrual disturbance and the potential for a delay in return to full fertility. Delayed return of fertility and irregular cycles may occur after discontinuation of treatment but there is no evidence of permanent infertility.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension",
                "oral solution"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75466",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75484",
                "label": "Suspension for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP85587",
                "label": "CONJUGATED OESTROGENS WITH MEDROXYPROGESTERONE",
                "type": "drug"
            },
            {
                "id": "PHP85597",
                "label": "ESTRADIOL WITH MEDROXYPROGESTERONE",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78143",
                "label": "Contraceptives, interactions",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78400",
                "label": "Sex hormones",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78485",
                "label": "Contraceptives, hormonal",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78591",
                "label": "Hormones, malignant disease",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_672",
                "label": "Medroxyprogesterone",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75466",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75484",
                "label": "Suspension for injection",
                "type": "medicinalForm"
            }
        ]
    }
}